Reinnervate
Reinnervate was founded in 2002 by Professor Stefan Przyborski as a spinout from Durham University, UK. Reinnervate was acquired by ReproCELL in 2014. The core strength of Reinnervate lies in its Alvetex® family of 3D cell culture products, providing a flexible platform that allows scientists in any life science laboratory to easily establish improved in vitro assays and tissue models that better mimic the in vivo growth of cells. Alvetex 3D cell culture systems have many applications in basic research, drug discovery and product development in the academic, biotechnology and pharmaceutical sectors. Wherever scientists need to better understand the growth, function and disease mechanisms of cells in vivo, Alvetex can provide more predictive and physiologically relevant cell culture models that more closely mimic real tissue structure and function. Alvetex enables the creation of tissue-like structures containing single or multiple cell-types in vitro - in traditional multi-well culture plastic ware. Cell morphology, gene and protein expression, and cell function are enhanced and greater cell-cell communication is established in both primary cells, established cell lines, and stem cell derivatives. Moreover, 3D cell cultures grown in Alvetex can be processed and imaged in the same manner as tissue biopsy samples and a wide range of downstream assays and applications can be performed, providing more translational results over conventional 2D cell culture systems.
About Reinnervate
Founded
2002Estimated Revenue
$10M-$50MEmployees
51-250Category
Industry
BiotechnologyLocation
City
SedgefieldState
County DurhamCountry
United KingdomReinnervate
Find your buyer within Reinnervate